Orfiril Long 300
Orfiril Long 300 is an originator product from Desitin Pharma GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 29.95 to CHF 29.95 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Desitin Pharma GmbH
- ATC code
- N03AG01
- IT group
- 01.07.10 Einfache Antiepileptica
- Active substances
- Natrii valproas
- Preparation type
- Originator product
- On the SL since
- 15/03/1999
- Last price change
- 01/09/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Ret Kaps 300 mg | 100 Stk | CHF 12.46 | CHF 29.95 | 15/03/1999 | B | 7680542680767 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Orfiril Long 300 covered by Swiss health insurance?
Yes. Orfiril Long 300 is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Orfiril Long 300 cost in Switzerland?
The public price is the maximum price set by the FOPH and for Orfiril Long 300 ranges from CHF 29.95 to CHF 29.95 per pack. The ex-factory price ranges from CHF 12.46 to CHF 12.46. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages